Crossmark

Short-term melatonin supplementation decreases oxidative stress but does not affect left ventricular structure and function in myxomatous mitral valve degenerative dogs

Crossref DOI link: https://doi.org/10.1186/s12917-021-03125-z

Published Online: 2022-01-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pongkan, Wanpitak

Piamsiri, Chanon

Dechvongya, Sirada

Punyapornwitthaya, Verasak

Boonyapakorn, Chavalit
License Information

Text and Data Mining valid from 2022-01-07

Version of Record valid from 2022-01-07
More Information

Article History

Received: 30 June 2021

Accepted: 20 December 2021

First Online: 7 January 2022

Declarations

:

: This study was approved by the Faculty of Veterinary Medicine Chiang Mai University Animal Care and Use Committee (FVM – ACUC) (approved ethical number: S17/2562) and written informed consent was obtained before the dogs were included in the study. All methods are reported in accordance with ARRIVE guidelines () for the reporting of animal experiments.

: Not applicable.

: The authors declare no conflicts of interest. This clinical trial was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest.

Document is current

Any future updates will be listed below